Barry Ticho Stoke Therapeutics, Inc. (STOK) insider trading activity

Barry Ticho is CHIEF MEDICAL OFFICER of Stoke Therapeutics, Inc.. Currently has a direct ownership of 60,629 shares of STOK, which is worth approximately $505,039. The most recent transaction as insider was on Mar 19, 2025, when has been sold 3,333 shares (Common Stock) at a price of $8.27 per share, resulting in proceeds of $27,563. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 60.6K

35.5% 3M change

428.63% 12M change

Total Value Held $505,039

Barry Ticho Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 19 2025	SELL Open market or private sale	$27,563 $8.27 p/Share	3,333 Reduced 5.21%	60,629 Common Stock
Mar 18 2025	SELL Open market or private sale	$33,674 $8.67 p/Share	3,884 Reduced 5.72%	63,962 Common Stock
Mar 15 2025	BUY Exercise of conversion of derivative security	-	23,100 Added 25.4%	67,846 Common Stock
Dec 09 2024	SELL Open market or private sale	$33,592 $12.99 p/Share	2,586 Reduced 5.46%	44,746 Common Stock
Dec 06 2024	SELL Open market or private sale	$178,217 $12.78 p/Share	13,945 Reduced 22.76%	47,332 Common Stock
Dec 03 2024	BUY Exercise of conversion of derivative security	-	10,000 Added 14.03%	61,277 Common Stock
Dec 02 2024	SELL Open market or private sale	$120,700 $12.07 p/Share	10,000 Reduced 16.32%	51,277 Common Stock
Dec 02 2024	BUY Exercise of conversion of derivative security	$6,000 $0.6 p/Share	10,000 Added 14.03%	61,277 Common Stock
Dec 01 2024	BUY Exercise of conversion of derivative security	-	48,792 Added 48.76%	51,277 Common Stock
Nov 01 2024	SELL Open market or private sale	$126,800 $12.68 p/Share	10,000 Reduced 80.1%	2,485 Common Stock
Nov 01 2024	BUY Exercise of conversion of derivative security	$6,000 $0.6 p/Share	10,000 Added 44.47%	12,485 Common Stock
Oct 01 2024	SELL Open market or private sale	$120,600 $12.06 p/Share	10,000 Reduced 80.1%	2,485 Common Stock
Oct 01 2024	BUY Exercise of conversion of derivative security	$6,000 $0.6 p/Share	10,000 Added 44.47%	12,485 Common Stock
Sep 03 2024	SELL Open market or private sale	$151,700 $15.17 p/Share	10,000 Reduced 80.1%	2,485 Common Stock
Sep 03 2024	BUY Exercise of conversion of derivative security	$6,000 $0.6 p/Share	10,000 Added 44.47%	12,485 Common Stock
Aug 01 2024	SELL Open market or private sale	$145,800 $14.58 p/Share	10,000 Reduced 80.1%	2,485 Common Stock
Aug 01 2024	BUY Exercise of conversion of derivative security	$6,000 $0.6 p/Share	10,000 Added 44.47%	12,485 Common Stock
Jul 01 2024	SELL Open market or private sale	$137,500 $13.75 p/Share	10,000 Reduced 80.1%	2,485 Common Stock
Jul 01 2024	BUY Exercise of conversion of derivative security	$6,000 $0.6 p/Share	10,000 Added 44.47%	12,485 Common Stock
Jun 03 2024	SELL Open market or private sale	$155,000 $15.5 p/Share	10,000 Reduced 80.1%	2,485 Common Stock
Jun 03 2024	BUY Exercise of conversion of derivative security	$6,000 $0.6 p/Share	10,000 Added 44.47%	12,485 Common Stock
May 01 2024	SELL Open market or private sale	$113,699 $11.37 p/Share	10,000 Reduced 80.1%	2,485 Common Stock
May 01 2024	BUY Exercise of conversion of derivative security	$6,000 $0.6 p/Share	10,000 Added 44.47%	12,485 Common Stock
Apr 01 2024	SELL Open market or private sale	$124,705 $13.23 p/Share	9,426 Reduced 79.14%	2,485 Common Stock
Apr 01 2024	BUY Exercise of conversion of derivative security	$265 $0.6 p/Share	442 Added 3.58%	11,911 Common Stock

Barry Ticho

CHIEF MEDICAL OFFICER

Bedford, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells STOK shares.

Notify only if

Value

Insider Trading

Get notified when an Stoke Therapeutics, Inc. insider buys or sells STOK shares.

Notify only if

Operation

Value

Type

News

Receive news related to Stoke Therapeutics, Inc.

Track Activities on STOK

Account